雜志介紹

Expert Opinion On Drug Metabolism & Toxicology雜志介紹

《Expert Opinion On Drug Metabolism & Toxicology》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱藥物代謝與毒理學(xué)專家意見，本刊主要出版、報道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.9，最新CiteScore 指數(shù)為7.9。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Pharmacokinetic mechanisms underlying the detoxification effect of Glycyrrhizae Radix et Rhizoma (Gancao): drug metabolizing enzymes, transporters, and beyond.

  Author: Li N¹, Zhou T², Wu F³, Wang R³, Zhao Q², Zhang JQ³, Yang BC¹, Ma BL².

• An update on polyphenol disposition via coupled metabolic pathways.

  Author: Wang L¹, Sun R¹, Zhang Q¹, Luo Q¹, Zeng S¹, Li X¹, Gong X¹, Li Y¹, Lu L¹, Hu M^1,2, Liu Z^1,3.

• Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases.

  Author: Barbosa ACS¹, Feng Y^1,2, Yu C³, Huang M⁴, Xie W^1,5.

• The influence of gut microbiota on drug metabolism and toxicity.

  Author: Li H, He J, Jia W.

英文介紹

Expert Opinion On Drug Metabolism & Toxicology雜志英文介紹

Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome:

Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data.

Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.

The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.